- Medical - Diagnostics & Research
- Healthcare
Charles River Laboratories International, Inc.
CRL · US ·
NYSE
201.93
USD
+1.97
(0.98%)
-
8.38
EPS
-
24.11
P/E
-
10.4B
MARKET CAP
-
0.00%
DIV YIELD
EPS Estimates
| 2023-12-30 | 2024-12-30 | 2025-12-30 | 2026-12-30 | 2027-12-30 | 2028-12-30 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 9.02 | 10.5 | 9.98 | 11.8 | 14.7 | 17.3 | 13.91% |
| Avg. Estimate | 8.66 | 10.3 | 9.16 | 11.3 | 14.1 | 16.6 | 13.91% |
| Low Estimate | 8.32 | 9.88 | 7.25 | 10.7 | 13.6 | 16 | 13.91% |
| No. Of Analysts | 12 | 13 | 10 | 4 | 1 | 2 |
Revenue Estimates
| 2023-12-30 | 2024-12-30 | 2025-12-30 | 2026-12-30 | 2027-12-30 | 2028-12-30 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 4.12B | 4.1B | 4.52B | 5B | 4.96B | 5.54B | 6.08% |
| Avg. Estimate | 4.11B | 4.06B | 4.49B | 4.84B | 4.8B | 5.36B | 5.46% |
| Low Estimate | 4.1B | 4.05B | 4.41B | 4.69B | 4.66B | 5.2B | 4.87% |
| No. Of Analysts | 11 | 11 | 12 | 12 | 6 | 5 |
Net Income Estimates
| 2023-12-30 | 2024-12-30 | 2025-12-30 | 2026-12-30 | 2027-12-30 | 2028-12-30 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 533M | 541M | 513M | 605M | 758M | 891M | 10.80% |
| Avg. Estimate | 444M | 528M | 506M | 590M | 728M | 855M | 13.98% |
| Low Estimate | 356M | 509M | 373M | 550M | 699M | 821M | 18.22% |
| No. Of Analysts | 11 | 11 | 12 | 12 | 6 | 5 |